Literature DB >> 19927162

Examination of FMR1 transcript and protein levels among 74 premutation carriers.

Emmanuel Peprah1, Weiya He, Emily Allen, Tiffany Oliver, Alex Boyne, Stephanie L Sherman.   

Abstract

Fragile X-associated disorders are caused by a CGG trinucleotide repeat expansion in the 5'-untranslated region of the FMR1 gene. Expansion of the CGG trinucleotide repeats to >200 copies (that is, a full mutation) induces methylation of the FMR1 gene, with transcriptional silencing being the eventual outcome. Previous data have shown that FMR1 premutation carriers (individuals with 55-199 repeats) have increased FMR1 mRNA levels with decreased protein (fragile X mental retardation protein (FMRP)) levels. However, the point at which this translational inefficiency occurs, given the increased transcription mechanism, has not yet been explored and remains to be elucidated. We examined the repeat length group, FMR1 transcript and FMRP levels in 74 males with a wide range of repeat lengths using analysis of covariance to better characterize this association. Results showed that the mean FMRP level among carriers with 80-89 repeats was significantly higher than the mean levels among lower (54-79) and higher (90-120) premutation carriers, in spite of the increasing transcript level with repeat length. Taken together, these results suggest that the 80-89-repeat group may lead to different properties that increase the efficiency of translation compared with other premutation repeat size groups.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19927162      PMCID: PMC4122982          DOI: 10.1038/jhg.2009.121

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  20 in total

1.  The active FMR1 promoter is associated with a large domain of altered chromatin conformation with embedded local histone modifications.

Authors:  Nele Gheldof; Tomoko M Tabuchi; Job Dekker
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-04       Impact factor: 11.205

2.  Long CGG-repeat tracts are toxic to human cells: implications for carriers of Fragile X premutation alleles.

Authors:  Vaishali Handa; Deena Goldwater; David Stiles; Margaret Cam; George Poy; Daman Kumari; Karen Usdin
Journal:  FEBS Lett       Date:  2005-04-18       Impact factor: 4.124

3.  Survey of the fragile X syndrome and the fragile X E syndrome in a special education needs population.

Authors:  K L Meadows; D Pettay; J Newman; J Hersey; A E Ashley; S L Sherman
Journal:  Am J Med Genet       Date:  1996-08-09

4.  Prevalence and phenotype consequence of FRAXA and FRAXE alleles in a large, ethnically diverse, special education-needs population.

Authors:  D C Crawford; K L Meadows; J L Newman; L F Taft; D L Pettay; L B Gold; S J Hersey; E F Hinkle; M L Stanfield; P Holmgreen; M Yeargin-Allsopp; C Boyle; S L Sherman
Journal:  Am J Hum Genet       Date:  1999-02       Impact factor: 11.025

5.  Elevated FMR1 mRNA in premutation carriers is due to increased transcription.

Authors:  Flora Tassone; Alexandra Beilina; Chiara Carosi; Serena Albertosi; Claudia Bagni; Lexin Li; Kira Glover; David Bentley; Paul J Hagerman
Journal:  RNA       Date:  2007-02-05       Impact factor: 4.942

6.  Differential expression of Fmr-1 mRNA and FMRP in female mice brain during aging.

Authors:  Kanchan Singh; S Prasad
Journal:  Mol Biol Rep       Date:  2007-09-27       Impact factor: 2.316

7.  Secondary structure and dynamics of the r(CGG) repeat in the mRNA of the fragile X mental retardation 1 (FMR1) gene.

Authors:  Marta Zumwalt; Anna Ludwig; Paul J Hagerman; Thorsten Dieckmann
Journal:  RNA Biol       Date:  2007-09-12       Impact factor: 4.652

8.  Analysis of FMR1 gene expression in female premutation carriers using robust segmented linear regression models.

Authors:  Eva García-Alegría; Berta Ibáñez; Mónica Mínguez; Marisa Poch; Alberto Valiente; Arantza Sanz-Parra; Cristina Martinez-Bouzas; Elena Beristain; Maria-Isabel Tejada
Journal:  RNA       Date:  2007-05       Impact factor: 4.942

9.  Fragile X syndrome: diagnostic and carrier testing.

Authors:  Stephanie Sherman; Beth A Pletcher; Deborah A Driscoll
Journal:  Genet Med       Date:  2005-10       Impact factor: 8.822

10.  ATR protects the genome against CGG.CCG-repeat expansion in Fragile X premutation mice.

Authors:  Ali Entezam; Karen Usdin
Journal:  Nucleic Acids Res       Date:  2007-12-26       Impact factor: 16.971

View more
  37 in total

1.  FXTAS in an unmethylated mosaic male with fragile X syndrome from Chile.

Authors:  L Santa María; A Pugin; M A Alliende; S Aliaga; B Curotto; T Aravena; H-T Tang; G Mendoza-Morales; R Hagerman; F Tassone
Journal:  Clin Genet       Date:  2013-10-13       Impact factor: 4.438

2.  Broad autism spectrum and obsessive-compulsive symptoms in adults with the fragile X premutation.

Authors:  A Schneider; C Johnston; F Tassone; S Sansone; R J Hagerman; E Ferrer; S M Rivera; D Hessl
Journal:  Clin Neuropsychol       Date:  2016-06-29       Impact factor: 3.535

3.  A GAG trinucleotide-repeat polymorphism in the gene for glutathione biosynthetic enzyme, GCLC, affects gene expression through translation.

Authors:  Sailendra N Nichenametla; Philip Lazarus; John P Richie
Journal:  FASEB J       Date:  2011-03-28       Impact factor: 5.191

4.  Reduced excitatory amino acid transporter 1 and metabotropic glutamate receptor 5 expression in the cerebellum of fragile X mental retardation gene 1 premutation carriers with fragile X-associated tremor/ataxia syndrome.

Authors:  Dalyir I Pretto; Madhur Kumar; Zhengyu Cao; Christopher L Cunningham; Blythe Durbin-Johnson; Lihong Qi; Robert Berman; Stephen C Noctor; Randi J Hagerman; Isaac N Pessah; Flora Tassone
Journal:  Neurobiol Aging       Date:  2013-11-16       Impact factor: 4.673

Review 5.  Fragile X syndrome: the FMR1 CGG repeat distribution among world populations.

Authors:  Emmanuel Peprah
Journal:  Ann Hum Genet       Date:  2011-12-21       Impact factor: 1.670

6.  Size and methylation mosaicism in males with Fragile X syndrome.

Authors:  Poonnada Jiraanont; Madhur Kumar; Hiu-Tung Tang; Glenda Espinal; Paul J Hagerman; Randi J Hagerman; Nuanchan Chutabhakdikul; Flora Tassone
Journal:  Expert Rev Mol Diagn       Date:  2017-11       Impact factor: 5.225

7.  Neuropathological, clinical and molecular pathology in female fragile X premutation carriers with and without FXTAS.

Authors:  F Tassone; C M Greco; M R Hunsaker; A L Seritan; R F Berman; L W Gane; S Jacquemont; K Basuta; L-W Jin; P J Hagerman; R J Hagerman
Journal:  Genes Brain Behav       Date:  2012-04-06       Impact factor: 3.449

8.  CNS expression of murine fragile X protein (FMRP) as a function of CGG-repeat size.

Authors:  Anna Lisa Ludwig; Glenda M Espinal; Dalyir I Pretto; Amanda L Jamal; Gloria Arque; Flora Tassone; Robert F Berman; Paul J Hagerman
Journal:  Hum Mol Genet       Date:  2014-01-23       Impact factor: 6.150

9.  Early mitochondrial abnormalities in hippocampal neurons cultured from Fmr1 pre-mutation mouse model.

Authors:  Eitan S Kaplan; Zhengyu Cao; Susan Hulsizer; Flora Tassone; Robert F Berman; Paul J Hagerman; Isaac N Pessah
Journal:  J Neurochem       Date:  2012-09-28       Impact factor: 5.372

10.  CGG allele size somatic mosaicism and methylation in FMR1 premutation alleles.

Authors:  Dalyir I Pretto; Guadalupe Mendoza-Morales; Joyce Lo; Ru Cao; Andrew Hadd; Gary J Latham; Blythe Durbin-Johnson; Randi Hagerman; Flora Tassone
Journal:  J Med Genet       Date:  2014-03-03       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.